Immune checkpoint inhibitors in EGFR-mutant non-small cell lung cancer: A systematic review.

Attili, Ilaria; Passaro, Antonio; Corvaja, Carla; Trillo Aliaga, Pamela; Del Signore, Ester; Spitaleri, Gianluca; de Marinis, Filippo.

Afiliação

Attili I; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy.
Passaro A; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy. Electronic address: antonio.passaro@ieo.it.
Corvaja C; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy.
Trillo Aliaga P; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy.
Del Signore E; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy.
Spitaleri G; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy.
de Marinis F; Division of Thoracic Oncology, European Institute of Oncology IRCCS, Via G. Ripamonti 435, 20141 Milan, Italy.

Cancer Treat Rev ; 119: 102602, 2023 Sep.

Article em En | MEDLINE | ID: mdl-37481836